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Available online 12 May 2016We compared genotype data from the HumanExomeCore Array in peripheral blood mononuclear cells and low
passage lymphoblastoid cell lines from the same 24 individuals to test for genotypic errors caused by the Ep-
stein–Barr Virus transformation process. Genotype concordance across the 24 comparisonswas 99.57% for unﬁl-
tered genotype data, and 99.63% following standard genotype quality control ﬁlters. Mendelian error rates and
levels of heterozygosity were not signiﬁcantly different between lymphoblastoid cell lines and their parent pe-
ripheral blood mononuclear cells. These results show that at low passage numbers, genotype discrepancies are
minimal even before stringent quality control, and extend current evidence qualifying the use of low-passage
lymphoblastoid cell lines as a reliable DNA source for genotype analysis.
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Lymphoblastoid cell lines (LCLs), which are human B lymphocytes
immortalized by in vitro infection with Epstein-Barr Virus (EBV), are a
renewable source of DNA, and an alternative to primary cells or tissue
samples as a source of genomic DNA. More and more DNA will be
required as the genomics era progresses from genome-wide association
studies towhole exome sequencing andwhole genome sequencing, and
studies are likely to utilise diverse sets of samples, possibly comprising
combinations of DNA from peripheral blood mononuclear cells
(PBMC) and LCLs.
A number of studies have shown that the immortalisation and/or
subsequent passaging of these LCLs may lead to new mutations and
genomic instability, including extended homozygosity, structural
genomic variation and changes in DNA methylation patterns [1–8].
These new non-germline mutations would confound association studies
of human disease, especially as the ﬁeldmoves towards rare variant anal-
ysis. Other studies have however indicated that LCLs with low passage
numbers display good genomic stability, with the EBV-transformation
process producing minor, if any, artefacts on genomic structure [9,10].
Two recent studies have reported high genotype concordance between
DNA from LCLs and their parent PBMCs at low passage numbers
(N 99%), especially after genotype quality control ﬁltering has beenarch in Neuropsychiatry, QEII
tralia.
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. This is an open access article underapplied [7,11], though there is evidence that high numbers of cell
passages may produce instability [7]. Similarly, a small number of
next-generation sequencing studies have reported that stringent ﬁlter-
ing parameters signiﬁcantly reduce discordant calls and validation
experiments indicate minimal differences between PBMC–LCL pairs
[6,10,12].
To add strength to the ﬁndings of the limited number of studies that
have assessed the validity of using LCL DNA in genetic studies, we have
tested for genotypic errors potentially induced by the EBV transforma-
tion process by comparing single nucleotide polymorphism (SNP) ge-
notype calls in PBMCs and LCLs from the same individuals (N = 24).
Our cohort included two family groups, allowing for the detection of
Mendelian errors. All samples were at early passage (b 5) and were
genotyped on the Illumina HumanExomeCore Array, which contains
N 500,000 common and ‘rarish’ SNPs. We report high concordance
between PBMC–LCL pairs, and contrary to previous studies, our data
donot showmarked overall improvement in concordance after applica-
tion of genotype quality control ﬁltering. These data support the use of
low passage LCL DNA in genetic studies where PBMC DNA from an
individual is unavailable/depleted.
2. Materials and methods
2.1. Sample collection and generation of LCLs
The study sample comprised 24 individuals from the Western
Australian Family Study of Schizophrenia [13] (WAFSS), including 16the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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family consisting of parents and 3 offspring, DNA was extracted using
standard protocols and stored frozen in 1XTE buffer. LCLswere generated
as described in Verbrugghe et al. [14] Brieﬂy, lymphocyteswere isolated
fromwhole blood samples using Ficoll Lymphocyte SeparationMedium
(MP Biochemicals). LCLs were established by transformation of fresh
lymphocytes with EBV and cultured in a T25 ﬂask in advanced RPMI
medium supplemented with 2% fetal calf serum, 2 mM L-glutamax,
50 units/ml penicillin/50 μg/ml streptomycin and 2% crude phytohe-
magglutinin (M Form) [Invitrogen, Carlsbad, CA, USA] in a humidiﬁed
environment at 37 °C in 5% (v/v) carbon dioxide. The culture wasmain-
tained in thismedia until it reached a cell density of 0.5–1× 106 cells/ml
in 20 ml. The cells were then transferred to a T75 ﬂask and allowed to
reach a density of ~1 × 106 cells/ml in 50–55ml. At this stage, an aliquot
of cells was removed for DNA isolation and the remaining cells cryopre-
served in duplicate in liquid nitrogen. DNA was isolated from the cells
using standard protocols and stored at−80 °C.
The study was approved by the Human Research Ethics Committee
of The University of Western Australia. Written informed consent was
obtained from all subjects.
2.2. Genotyping
Genotyping on the Illumina HumanCoreExome beadchip-12v1-1_A
was performed at Pathwest, QEII Medical Centre (Nedlands, WA,
Australia) according to manufacturer's instructions. The chip assays
approximately 250,000 common [minor allele frequency (MAF) N 5%]
and 250,000 ‘rarish’ exonic SNPs (MAF 1–5%); details on the history
and content of the chip can be found at http://genome.sph.umich.edu/
wiki/Exome_Chip_Design.
2.3. Quality control
For the ‘unﬁltered’ analysis, all 542,585 SNPs on the chip were
compared between the 24 PBMC–LCL pairs. In order to assess whether
concordance levels were improved following standard genotyping
quality control measures, the quality control ﬁlters described in
Table 1 were applied to the genotype data using PLINK [15] (http://
pngu.mgh.harvard.edu/purcell/plink/). Rates of SNP heterozygosity
were also calculated for each sample across the 232,171 autosomal
markers which were polymorphic in this population. In addition, to
provide a baseline error rate for this assay, 6 PBMC samples were
genotyped in duplicate on the same 542,585 SNPs.Table 1
Sample (upper panel) and SNP (lower panel) quality control exclusions for the 24 PBMC-LCL p
values. MAF— minor allele frequency; HWE — Hardy Weinberg equilibrium.
Samples
Total samples
Sample exclusions
Genotypes inconsistent with phenotypic sex
Samples with N10% of SNP genotypes missing
Samples with N5% SNPs showing Mendelian errors
Final samples remaining after exclusions
SNPs PBMCs (n= 24)
Total SNPs 542,585
Average call rate (sd; range) % 99.10 (1.08; 95.90–99
SNP exclusions
SNPs with N10% of genotypes missing 11,073 (2.04%)
SNPs remaining with ≥ 90% genotype rate 531,512
SNPs with minor allele frequency (MAF) b 5% 294,074 (55.32%)
SNPs remaining with MAF ≥ 5% 237,438
SNPs not in HWE (bP= 0.001) 0
SNPs remaining in HWE (≥P= 0.001) 237,438
SNPs with N10% Mendel error rate 9 (0.004%)
SNPs remaining with ≤ 90%Mendel error rate 237,429
Final SNPs remaining after exclusions 237,429 (43.76%)2.4. Statistical analysis
Tests of equal proportions were performed using the two-Sample
test for equality of proportions as implemented in the prop.test function
in the R package ‘stats’, or the paired test pairwise.prop.testwith correc-
tion for multiple testing when comparing groups.
2.5. Results
Call rate as a proportion of the 542,585 SNPs on the chip was signif-
icantly lower overall for PBMCs than for LCLs (P b 2.2 × 10−16; Table 1)
and remained signiﬁcant after adjusting for between-sample variability
(paired test of proportions P= 0.001). Application of the control ﬁlters
(Table 1) to PBMC and LCL datasets resulted in a signiﬁcantly different
proportions of SNPs being removed due to MAF ﬁltering and
missingness. Following these exclusions, 237,429 and 239,448 SNPs
remained in the PBMC and LCL datasets, respectively. Call rate was sig-
niﬁcantly different between most individual PBMC–LCL pairs (P b 0.05;
Table 2 and Fig. 1), whereas genome wide rates of heterozygosity
and number of Mendelian errors based on the ﬁltered data were not
signiﬁcantly different between individual pairs (Table 2), or overall.
Genotype concordance between individual PBMC–LCL pairs was
high across unﬁltered (range 0.969–1.000, mean = 0.996, SD =
0.007) and QC ﬁltered (range 0.979–0.998, mean = 0.996, SD =
0.004) datasets (Table 2 and Fig. 1). However, concordance between
each individual pair for unﬁltered and ﬁltered SNP sets was signiﬁcantly
different (Table 2), although the direction of effect varied between sam-
ples. On average, there was a non-signiﬁcant increase in concordance
across all 24 pairs following quality control ﬁltering (paired t-test,
P = 0.715). By comparison, genotyping rate was 99.21% in the 6
PBMCs genotyped in duplicate (12 samples in total). Concordance
between the genotypes in each replicate pair was 100%.
There were no associations with sample age or sex for any of the
quality control measures or concordance rates (linear/logistic regres-
sion, P N 0.05).
3. Discussion
This study provides further evidence for minimal rates of discordant
genotypes between PBMC and LCL pairs at low passage numbers,
supporting the use of low-passage LCLs as a reliable DNA source for ge-
notype analysis. Contrary to previous reports, there was no signiﬁcant
increase in concordance rates after stringent quality control ﬁltering of
the genotype data. We were able to check Mendelian error rates inairs. P values are for 2-sample tests for equality of proportions between the PBMC and LCL
24
0
0
0
24
LCLs (n= 24) P
542,585
.90) 99.90 (0.08; 99.50–99.90) b 2.2e−16
959 (0.18%) b 2.2e−16
541,626
302,164 (55.79%) 1.2E−06
239,462
0 NA
239,462
14 (0.006%) 0.41
239,448
239,448 (44.13%) 9.5E−05
Table 2
Comparative data for individual PBMC–LCL pairs analysed in the study (N=24). Theﬁrst panel shows the comparison in call rate in the unﬁltered (n=542.585) SNP set. The secondpanel
shows a comparisonof heterozygosity levels based onQC-ﬁltered autosomal SNPs common to bothPBMCand LCLdatasets (n=232.171). In the third panel,Mendelian errors are reported
for the twonuclear families present in the sample— one trio (FID F_3), and one family consisting of parents and 3 offspring (FID F_15). For theseﬁrst three panels, P values are for 2-sample
test for equality of proportions between individual PBMC and LCL pairs. The fourth panel shows concordance rates between PBMC–LCL pairs before and after QC ﬁltering of SNPs. P values
are for 2-sample test for equality of proportions (concordance) between unﬁltered and ﬁltered data. IID: individual ID; FID: Family ID; PID: paternal ID; MID:maternal ID; Sex: M—male,
F — female; Age: age of the individual at the time of blood collection.
% call rate
(nSNPs = 542,585)
% heterozygosity
(nSNPs = 232,171)
Mendelian errors
(nSNPs 237,429)
Concordance rate between PBMC–LCL
pairs
PIID FID PID MID SEX AGE PBMC LCL P PBMC LCL P PBMC LCL P
Unﬁltered,
nSNPs = 542,585
QC ﬁltered,
nSNPs = 237 .429
1 F_1 25 26 M 31 0.983 0.999 b2e−16 0.379 0.380 0.834 − − − 0.995 0.996 b2.2e−16
2 F_2 27 28 M 33 , 0.999 b2e−16 0.381 0.381 0.946 − − − 0.995 0.996 9.8e−15
3 F_3 5 4 F 34 0.999 0.999 1.5E−03 0.428 0.428 0.678 58 60 1 1.000 0.998 b2.2e−16
4 F_3 − − F 62 0.999 0.999 8.5E−01 0.395 0.394 0.674 31 32 1 1.000 0.998 b2.2e−16
5 F_3 − − M 64 0.999 0.999 2.7E−05 0.456 0.455 0.630 29 30 1 1.000 0.998 b2.2e−16
6 F_4 29 30 M 25 0.983 0.999 b2e−16 0.376 0.376 0.889 − − − 0.995 0.997 b2.2e−16
7 F_5 31 32 M 26 0.999 0.999 6.9E−01 0.378 0.378 0.946 − − − 0.999 0.998 b2.2e−16
8 F_6 33 34 M 31 0.981 0.995 b2e−16 0.377 0.377 0.946 − − − 0.992 0.996 b2.2e−16
9 F_7 35 36 M 37 0.999 0.999 3.9E−05 0.379 0.379 0.946 − − − 1.000 0.998 b2.2e−16
10 F_8 37 38 M 28 0.999 0.999 1.2E−01 0.380 0.380 0.889 − − − 1.000 0.998 b2.2e−16
11 F_9 39 40 M 20 0.982 0.999 b2e−16 0.372 0.372 0.946 − − − 0.993 0.997 b2.2e−16
12 F_10 41 42 M 25 0.981 0.999 b2e−16 0.380 0.380 1.000 − − − 0.993 0.996 b2.2e−16
13 F_11 43 44 M 33 0.999 0.999 1.3E−01 0.380 0.380 0.889 − − − 1.000 0.998 b2.2e−16
14 F_12 45 46 M 30 0.959 0.999 b2e−16 0.380 0.381 0.437 − − − 0.969 0.979 b2.2e−16
15 F_13 47 48 F 45 0.999 0.999 6.7E−01 0.382 0.381 0.946 − − − 1.000 0.998 b2.2e−16
16 F_14 49 50 F 38 0.979 0.999 b2e−16 0.376 0.375 0.621 − − − 0.986 0.987 4.2e−05
17 F_15 19 18 M 23 0.983 0.999 b2e−16 0.416 0.416 0.782 61 64 1 0.994 0.997 b2.2e−16
18 F_15 − − F 55 0.983 0.999 b2e−16 0.416 0.416 0.947 61 60 1 0.995 0.997 b2.2e−16
19 F_15 − − M 54 0.983 0.999 b2e−16 0.416 0.416 0.891 57 52 1 0.995 0.997 b2.2e−16
20 F_15 19 18 M 27 0.999 0.999 5.0E−01 0.414 0.414 0.891 27 19 1 1.000 0.998 b2.2e−16
21 F_15 19 18 F 25 0.999 0.999 3.2E−01 0.415 0.415 0.891 26 26 1 1.000 0.998 b2.2e−16
22 F_16 51 52 F 32 0.999 0.999 2.1E−01 0.381 0.381 1.000 − − − 0.999 0.998 b2.2e−16
23 F_16 51 52 F 35 0.999 0.999 1.0E+00 0.384 0.384 0.946 − − − 1.000 0.998 b2.2e−16
24 F_17 53 54 M 20 0.999 0.999 1.9E−05 0.378 0.377 0.889 − − − 1.000 0.998 b2.2e−16
20 N.S. McCarthy et al. / Genomics Data 9 (2016) 18–21our two family groups, and report comparable rates of Mendelian error
in PBMC and LCL DNA. Surprisingly, we report signiﬁcantly higher geno-
type call rates in the LCL DNA, whichmay indicate some degradation of
the PBMC DNA.
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